Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL376049 | 0.83 | — | — | |
| SCHEMBL375938 | 0.81 | — | — | |
| SCHEMBL375424 | 0.80 | — | — | |
| SCHEMBL734469 | 0.78 | LMNA (0.35) | LMNATHRB | |
| SCHEMBL375211 | 0.77 | DNM1 (0.38) | — | |
| SCHEMBL375710 | 0.77 | DNM1 (0.38) | — | |
| SCHEMBL375876 | 0.77 | — | — | |
| SCHEMBL22346066 | 0.77 | LMNA (0.41) | LMNATHRB | |
| SCHEMBL375620 | 0.76 | — | — | |
| SCHEMBL375770 | 0.74 | THRB (0.45) | LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7518009-B2 | Process for preparing mercaptoorganyl (alkoxysilanes) | EVONIK DEGUSSA GMBH (DE) | 2009-04-14 | — | — | US | claimed |
| US-20060252952-A1 | Process for preparing mercaptoorganyl (alkoxysilanes) | DEGUSSA AG (DE) | 2006-11-09 | — | — | US | claimed |
| US-12570899-B2 | Bright silver based quaternary nanostructures | SHOEI CHEMICAL INC. (JP) | 2026-03-10 | — | — | US | disclosed |
| CN-115678542-B | Quaternary nanostructure based on bright silver | 昭荣化学工业株式会社 | 2024-12-31 | — | — | CN | disclosed |
| US-20240263069-A1 | BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES | SHOEI CHEMICAL INC. (JP) | 2024-08-08 | — | — | US | disclosed |
| US-11970646-B2 | Bright silver based quaternary nanostructures | SHOEI CHEMICAL INC. (JP) | 2024-04-30 | — | — | US | disclosed |
| CN-112724405-B | Curing agent mixture | 赢创运营有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-115678542-A | Quaternary nanostructure based on bright silver | 纳米系统公司 | 2023-02-03 | — | — | CN | disclosed |
| EP-3816247-B1 | CURING MIXTURE | EVONIK OPERATIONS GMBH (DE) | 2022-12-07 | — | — | EP | disclosed |
| CN-113840895-B | Quaternary nanostructure based on bright silver | 纳米系统公司 | 2022-11-15 | — | — | CN | disclosed |
| US-20220228057-A1 | BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES | NANOSYS, INC. (US) | 2022-07-21 | — | — | US | disclosed |
| EP-1634884-B1 | Process for preparing mercaptoorganyl alkoxy silanes | DEGUSSA (DE) | 2007-02-14 | — | — | EP | disclosed |
| EP-1734045-A1 | Process for preparing mercaptoorganyl alkoxy silanes | Degussa AG (DE) | 2006-12-20 | — | — | EP | disclosed |
| US-20060252952-A1 | Process for preparing mercaptoorganyl (alkoxysilanes) | DEGUSSA AG (DE) | 2006-11-09 | — | — | US | disclosed |
| US-20060204422-A1 | Process for the preparation of organosilanes | EVONIK OPERATIONS GMBH (DE) | 2006-09-14 | — | — | US | disclosed |
| EP-1700861-A1 | Process for preparing organosilanes | Degussa GmbH (DE) | 2006-09-13 | — | — | EP | disclosed |
| EP-1637535-A1 | Process for preparing mercaptoorganyl alkoxy silanes | Degussa GmbH (DE) | 2006-03-22 | — | — | EP | disclosed |
| EP-1634884-A1 | Process for preparing mercaptoorganyl alkoxy silanes | Degussa GmbH (DE) | 2006-03-15 | — | — | EP | disclosed |
| US-20060052622-A1 | Process for the preparation of mercaptoorganyl (alkoxysilanes) | EVONIK DEGUSSA GMBH (DE) | 2006-03-09 | — | — | US | disclosed |
| US-20060052621-A1 | Process for producing mercaptoorganyl (alkoxysilane) | EVONIK DEGUSSA GMBH (DE) | 2006-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570899-B2 | Bright silver based quaternary nanostructures | LGALS3, ANXA3, ATXN2L | LMNA 3108/4885THRB 2016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.